5 research outputs found
Additional file 1: Table S1. of Safety and efficacy of daclizumab in relapsing-remitting multiple sclerosis: 3-year results from the SELECTED open-label extension study
List of IECs and/or IRBs for SELECTED. (DOCX 20Â kb
5 research outputs found